Trials / Completed
CompletedNCT02257060
LINEAR II - LME-159 Evaluation of a Multi-Electrode Linear Type Ablation Catheter
Evaluation of a Multi-Electrode Linear Type Ablation Catheter for Endocardial Ablation of Patients With Right Atrial Flutter
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Biosense Webster, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Linear II study is a prospective, single center, non-randomized, interventional feasibility study with the purpose of assessing acute safety of the Multi-Electrode Linear Type Ablation Catheter and the performance of the product when used for the treatment of symptomatic CTI (cavotricuspid isthmus) dependent right atrial flutter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endocardial Ablation |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-11-01
- Completion
- 2015-05-01
- First posted
- 2014-10-06
- Last updated
- 2025-02-03
Source: ClinicalTrials.gov record NCT02257060. Inclusion in this directory is not an endorsement.